Insider Transactions in Q2 2025 at Maravai Lifesciences Holdings, Inc. (MRVI)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2025
|
Rajesh Asarpota Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
500,000
+50.0%
|
-
|
|
Jun 16
2025
|
Murali Prahalad Director |
BUY
Grant, award, or other acquisition
|
Direct |
89,139
+36.57%
|
$178,278
$2.16 P/Share
|
|
Jun 16
2025
|
Gregory T Lucier Director |
BUY
Grant, award, or other acquisition
|
Direct |
89,139
+38.19%
|
$178,278
$2.16 P/Share
|
|
Jun 16
2025
|
Luke Joseph Marker Director |
BUY
Grant, award, or other acquisition
|
Direct |
89,139
+39.23%
|
$178,278
$2.16 P/Share
|
|
Jun 16
2025
|
Susannah Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
89,139
+34.41%
|
$178,278
$2.16 P/Share
|
|
Jun 16
2025
|
Benjamin James Daverman Director |
BUY
Grant, award, or other acquisition
|
Direct |
89,139
+39.23%
|
$178,278
$2.16 P/Share
|
|
Jun 16
2025
|
John A De Ford Director |
BUY
Grant, award, or other acquisition
|
Direct |
89,139
+35.9%
|
$178,278
$2.16 P/Share
|
|
Jun 16
2025
|
Jessica Hopfield Director |
BUY
Grant, award, or other acquisition
|
Direct |
89,139
+30.84%
|
$178,278
$2.16 P/Share
|
|
Jun 16
2025
|
Constantine S Mihas Director |
BUY
Grant, award, or other acquisition
|
Direct |
89,139
+39.23%
|
$178,278
$2.16 P/Share
|
|
Jun 16
2025
|
R Andrew Eckert Director |
BUY
Grant, award, or other acquisition
|
Direct |
231,481
+38.75%
|
$462,962
$2.16 P/Share
|
|
Jun 16
2025
|
Sean Laurence Cunningham Director |
BUY
Grant, award, or other acquisition
|
Direct |
89,139
+39.23%
|
$178,278
$2.16 P/Share
|
|
Jun 08
2025
|
Bernd Brust Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000,000
+50.0%
|
-
|
|
May 15
2025
|
Christine Dolan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,381
+0.5%
|
$2,381
$1.67 P/Share
|
|
May 15
2025
|
Kevin Herde Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
876
+0.13%
|
$876
$1.67 P/Share
|